Utah Medical Products (UTMD) Gross Profit (2010 - 2026)

Utah Medical Products has reported Gross Profit for 17 years, with the latest figure at $4.8 million in Q2 2026.

• On a quarterly basis, Gross Profit fell 14.96% year-over-year to $4.8 million in Q2 2026; TTM through Jun 2026 was $20.9 million, a 6.07% decrease from a year earlier, with the FY2025 full-year figure at $22.0 million, down 8.87% from the prior year.
• Gross Profit was $4.8 million for Q2 2026 at Utah Medical Products, down from $5.3 million in the prior quarter.
• The five-year high for Gross Profit was $8.3 million in Q4 2022, with the low at $4.8 million in Q2 2026.
• Average Gross Profit over 5 years is $6.6 million, with a median of $6.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit rose 8.44% in 2022, then declined 25.01% in 2024.
• Over 5 years, Gross Profit stood at $8.3 million in 2022, then slipped by 14.76% to $7.1 million in 2023, then slipped by 25.01% to $5.3 million in 2024, then declined by 1.11% to $5.3 million in 2025, then declined by 9.61% to $4.8 million in 2026.
• The last three Gross Profit figures came in at $4.8 million (Q2 2026), $5.3 million (Q1 2026), and $5.3 million (Q4 2025), per Business Quant data.